Literature DB >> 1978777

Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.

H E Zhau1, X Zhang, A C von Eschenbach, K Scorsone, R J Babaian, J Y Ro, M C Hung.   

Abstract

The c-erb B-2/neu gene encodes a cell-surface glycoprotein with extensive homology to, but distinct from, the epidermal growth-factor receptor. In this study, we compared the c-erb B-2/neu gene amplification and expression of tissue specimens obtained from the bladders of normal controls and patients with high-grade transitional cell bladder carcinoma. Southern blot analysis of DNAs from 24 patients and 5 controls showed 2 cases of c-erb B-2/neu gene amplification in patients and none in controls. Western blot analysis demonstrated that c-erb B-2/neu was expressed in 67.6% (23/34) of patient specimens but in none of the controls (0/5). This finding agreed with the result of immunohistochemical staining, which showed that tissue from 74.3% (26/35) of the patients and none of the controls (0/7) showed positive immunofluorescence staining. This is the first report suggesting that c-erb B-2/neu gene amplification may be associated with human bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1978777     DOI: 10.1002/mc.2940030503

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  18 in total

1.  Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis.

Authors:  M Loda; P Capodieci; R Mishra; H Yao; C Corless; W Grigioni; Y Wang; C Magi-Galluzzi; P J Stork
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 2.  Growth factors in bladder cancer.

Authors:  M Liebert
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 3.  Prognostic role of HER2 expression in bladder cancer: a systematic review and meta-analysis.

Authors:  Junjie Zhao; Weidong Xu; Zhensheng Zhang; Ruixiang Song; Shuxiong Zeng; Yinghao Sun; Chuanliang Xu
Journal:  Int Urol Nephrol       Date:  2014-11-11       Impact factor: 2.370

Review 4.  Novel strategies for treating relapsed/refractory urothelial carcinoma.

Authors:  Gopa Iyer; Matthew I Milowsky; Dean F Bajorin
Journal:  Expert Rev Anticancer Ther       Date:  2010-12       Impact factor: 4.512

5.  Immunohistochemistry as an important tool in biomarkers detection and clinical practice.

Authors:  Leandro Luongo de Matos; Damila Cristina Trufelli; Maria Graciela Luongo de Matos; Maria Aparecida da Silva Pinhal
Journal:  Biomark Insights       Date:  2010-02-09

6.  Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy.

Authors:  Surendra B Kolla; Amlesh Seth; Manoj K Singh; Narmada P Gupta; Ashok K Hemal; Prem N Dogra; Rajeev Kumar
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

7.  p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer.

Authors:  H Moch; G Sauter; D Moore; M J Mihatsch; F Gudat; F Waldman
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 8.  Molecular prognostic factors in bladder cancer.

Authors:  J A Vet; F M Debruyne; J A Schalken
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

9.  Evaluation of the Expression of HER2 and c-KIT Proteins as Prognostic Markers in Superficial Bladder Urothelial Carcinoma.

Authors:  Wael Abdou Hassan; Essam Shalaby; Mona Abo-Hashesh; Rehab Ibrahim Ali
Journal:  Res Rep Urol       Date:  2021-05-05

10.  Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder.

Authors:  Khaled El Gehani; Lamia Al-Kikhia; Fatma Emaetig; Kari Syrjänen; Omran Al-Fituri; Adam Elzagheid
Journal:  Libyan J Med       Date:  2012-03-08       Impact factor: 1.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.